Drawing for ALGA BIOLOGICS

USPTO serial 79412399

ALGA BIOLOGICS

Reviewed by CopyMark Law Group

Reg. 8182125Status 700Registered
Filing date
Status date
Registration date
Mar 24, 2026
Examiner
NOLASCO-ARIAS, KENNETH E
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ALGA BIOLOGICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James J. Bitetto

James J. Bitetto Tutunjian & Bitetto, P.C.401 Broadhollow RoadSuite 402Melville, NY 11747

Goods and services

ClassDescriptionStatusFirst use
001Glycoproteins for industrial use; protein in raw material form for scientific and medical research; recombinant nucleic acid, other than for medical or veterinary purposes; enzymes for industrial use; enzymes for scientific use; enzymes for use in the industrial biotechnology and biopharmaceutical industry; enzymes other than for medical use for marking protein fractions; enzymes derived from biotechnological processes for industrial use; enzymes for protein hydrolysis, other than for medical or veterinary purposes; cell culture media for the biotechnology industry, other than for medical or veterinary purposes; nucleoproteins, other than for medical or veterinary purposes; biochemical products, namely, precursors for in-vitro genetic engineering; biochemical products, namely, monoclonal antibodies for in vitro scientific research use; biochemical preparations for in-vitro and in-vivo scientific use; biochemical preparations, other than for medical or veterinary purposes; plant extracts, other than essential oils, for the manufacture of cosmetics; proteins intended for the manufacture of food; protein in raw material form for manufacturing food for humans; raw proteins for scientific and medical research; raw proteins for use in industry; proteins for use in industry; proteins for the manufacture of cosmetic products; proteins for the food industry; proteins for the manufacture of food supplements; proteins for recombinant DNA techniques, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary useACTIVE—
005Human immunoglobulin for medical use; biotechnological preparations for medical use, namely, antibodies, recombinant proteins, and complex peptides for diagnostics and treatment of cancer and other human diseases; sanitary products, namely, formulation preparations for medical use for medicine; pharmaceutical products for the prevention, diagnostics, and treatment of cancer and other human diseases; veterinary products, namely, recombinant proteins, vaccines, and biologic therapeutics for veterinary use; food supplements; disinfectants; fungicidesACTIVE—
042Scientific research; technological research in the field of industrial biotechnology and biopharmaceuticals; engineering services, namely, technical testing in the field of industrial biotechnology and biopharmaceuticals; software development; software design; research and development of new products for third parties in the field of industrial biotechnology and biopharmaceuticals; scientific and technological research services, namely, conducting of technical project studies in the field of industrial biotechnology and biopharmaceuticals; computer system analysis; computer system design; consultant services with respect to computer hardware design and development; software as a service (SaaS) services featuring software for managing, optimizing and monitoring recombinant protein production workflows in microalgae, including digital tracking of strains, culture conditions, expression data and analyses in the field of biotechnology; providing technology information in the field of industrial biotechnology and biopharmaceuticals; design and development of operating software for accessing and using a cloud computing networkACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 31, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 30, 2026FIMPFINAL DISPOSITION PROCESSED—
Jun 24, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 4, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 18, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 24, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 24, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 3, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 3, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 28, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 12, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 12, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 12, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 12, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 3, 2025RFNTREFUSAL PROCESSED BY IB—
Sep 16, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 16, 2025RFRRREFUSAL PROCESSED BY MPU—
Aug 6, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 5, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2025DOCKASSIGNED TO EXAMINER—
Jul 31, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 31, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance